Webcast CME

Length - Pulmonology

 Filter Results
Series: (Optional)
Length: (Optional)
Sort by: Latest Top Rated
Risk Stratification and Current Treatment Algorithm
3.6 / 4.00
Risk Stratification and Current Treatment Algorithm
Faculty: Anthony R Cucci, MD
CME: Yes
Length: 30 minutes
Release Date: 1/4/2023 12:00:00 AM
Expiration Date: 01/04/2025
Advances in the Diagnostic and Hemodynamic Evaluation of PH
3.61 / 4.00
Advances in the Diagnostic and Hemodynamic Evaluation of PH
Faculty: Brad Maron, MD
CME: Yes
Length: 30 minutes
Release Date: 1/4/2023 12:00:00 AM
Expiration Date: 01/04/2025
PH in HFpEF: What can we do?
3.59 / 4.00
PH in HFpEF: What can we do?
Faculty: Sanjeeb Bhattacharya, MD
CME: Yes
Length:
Release Date: 1/4/2023 12:00:00 AM
Expiration Date: 01/04/2025
PH in ILD: Finally some hope?
3.65 / 4.00
PH in ILD: Finally some hope?
Faculty: Kristin Highland, MD
CME: Yes
Length: 30 minutes
Release Date: 1/4/2023 12:00:00 AM
Expiration Date: 01/04/2025
Chronic Thromboembolic PH
3.68 / 4.00
Chronic Thromboembolic PH
Faculty: Alice Goyanes, MD
CME: Yes
Length: 30 minutes
Release Date: 1/4/2023 12:00:00 AM
Expiration Date: 01/04/2025
PVDOMICs
3.62 / 4.00
PVDOMICs
Faculty: Anna R. Hemnes, MD
CME: Yes
Length: 30 minutes
Release Date: 1/4/2023 12:00:00 AM
Expiration Date: 01/04/2025
Testing, Risk Factors and the Clinical Spectrum of Lung Disease for Alpha-1 Antitrypsin Deficiency
3.7 / 4.00
Testing, Risk Factors and the Clinical Spectrum of Lung Disease for Alpha-1 Antitrypsin Deficiency
Faculty: James Stoller, MD; Charlie Strange, MD; Robert Sandhaus, MD; Lauren Palange, MS
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Testing, Prevalence, and Augmentation Therapy for Alpha-1 Antitrypsin Deficiency
3.73 / 4.00
Testing, Prevalence, and Augmentation Therapy for Alpha-1 Antitrypsin Deficiency
Faculty: James Stoller, MD; Robert Sandhaus, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
The Epidemiology and Treatment Options for Alpha-1 Antitrypsin Deficiency
3.66 / 4.00
The Epidemiology and Treatment Options for Alpha-1 Antitrypsin Deficiency
Faculty: Umur Hatipoglu, MD; Michael Campos
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Enhancing Detection, Individualized Treatment Plans, and Insurance Implications of Diagnosing Alpha-1 Antitrypsin Deficiency
3.63 / 4.00
Enhancing Detection, Individualized Treatment Plans, and Insurance Implications of Diagnosing Alpha-1 Antitrypsin Deficiency
Faculty: James Stoller, MD; Charlie Strange, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025